Novocure

Novocure

Medical Devices, 195 Commerce Way, Root, New Hampshire, 03801, United States, 1001-5000 Employees

novocure.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 60********

Who is NOVOCURE

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor T...

Read More

map
  • 195 Commerce Way, Root, New Hampshire, 03801, United States Headquarters: 195 Commerce Way, Root, New Hampshire, 03801, United States
  • 2000 Date Founded: 2000
  • 1001-5000 Employees: 1001-5000
  • dollar-icon Revenue: $250 Million to $500 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from NOVOCURE

Novocure Org Chart and Mapping

Employees

Nurpesh Patel

Senior Director, Us Cns Cancers Marketing

Meaghan Corbett

Revenue Operations Intern

Mark Hurley

Senior Manager, Human Resources Business Partners

Rachel Schaefer

Device Support Specialist

Beth Bencel

Administration Manager

Phillip Munson

Medical Science Liaison

Justin Chong

Oncology Global Marketing and Portfolio Strategy Extern

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Novocure

Answer: Novocure's headquarters are located at 195 Commerce Way, Root, New Hampshire, 03801, United States

Answer: Novocure's phone number is 60********

Answer: Novocure's official website is https://novocure.com

Answer: Novocure's revenue is $250 Million to $500 Million

Answer: Novocure's SIC: 3841

Answer: Novocure's NAICS: 561110

Answer: Novocure has 1001-5000 employees

Answer: Novocure is in Medical Devices

Answer: Novocure contact info: Phone number: 60******** Website: https://novocure.com

Answer: We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer. Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire, Chesterbrook, Pennsylvania and New York City. Additionally, Novocure has offices in Canada, Germany, Jersey, Japan and Israel.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access